Stereotactic body radiotherapy (SBRT) for pulmonary metastases from renal cell carcinoma—a multicenter analysis of the German working group “Stereotactic Radiotherapy”

BACKGROUND: Renal cell carcinoma (RCC) is traditionally considered to be radioresistant. Radiotherapy response rates are believed to improve with hypofractionated, high dose stereotactic body radiotherapy (SBRT). However, limited data exist regarding the role of SBRT in the treatment of pulmonary me...

Full description

Saved in:
Bibliographic Details
Published in:J Thorac Dis
Main Authors: Hoerner-Rieber, Juliane, Duma, Marciana, Blanck, Oliver, Hildebrandt, Guido, Wittig, Andrea, Lohaus, Fabian, Flentje, Michael, Mantel, Frederick, Krempien, Robert, Eble, Michael J., Kahl, Klaus Henning, Boda-Heggemann, Judit, Rieken, Stefan, Guckenberger, Matthias
Format: Artigo
Language:Inglês
Published: AME Publishing Company 2017
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5721071/
https://ncbi.nlm.nih.gov/pubmed/29268521
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2017.10.108
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items